# NCT05630183 (NCT05630183)

> A Study of Botensilimab in Participants With Metastatic Pancreatic Cancer

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT05630183
- Phase: PHASE2
- Status: COMPLETED
- Sponsor: Agenus Inc.
- Conditions: Metastatic Pancreatic Ductal Adenocarcinoma
- Interventions: Botensilimab; Gemcitabine; Nab-paclitaxel
- Enrollment: 81
- Primary outcome: Progression-free Survival as Assessed by Investigator

## Preliminary discovery

Commentary in our index that names this trial so far. Final coverage is set when the report is built.

- Bluesky threads: 3
- Podcasts: 2
- X threads: 2

## Order

Focused, $750, price fixed at order: https://www.erudio.com/contact?report=nct05630183